Assessment of Efficacy and Safety of Therapy With COVID-19 Convalescent Plasma in Subjects With Severe COVID-19 (IPCO)

Clinical trial NCT04712344 · UNKNOWN

Trial details

NCT number: NCT04712344
Sponsor: University of Erlangen-Nürnberg Medical School
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Severe COVID-19

Start date: 2021-01-18
Primary completion: 2021-09-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.